NEW YORK (GenomeWeb News) – Cellectis Bioresearch today announced a collaboration with Axxam to offer integrated discovery services based on genomic engineering technologies.

According to Cellectis, a genome engineering firm, the collaboration will offer a one-stop shop approach to generating cell-based assays to the life science industry. Cellectis will use its genome engineering methods to modify genes of interest, and then Axxam will apply its expertise and technologies for cell line generation to develop functional cellular assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."